Published Ahead of Print

cGAS–STING pathway activation drives the cold-to-hot tumor transition and sensitizes immunotherapy

Dietary restriction during active cancer therapy is associated with improved treatment response: a systematic review and meta-analysis

Rethinking nasopharyngeal carcinoma management: toward a low-toxicity, highly effective regimen with favorable tolerability and quality of life

Apatinib enhances targeted immunotherapy via the IL-6-gp130-PI3K pathway in HER2-positive gastric cancer

FDX1 expression promotes DSF/Cu-induced cuproptosis in gastric cancer cells

Myeloid cell reprogramming combined with zoledronic acid effectively suppresses bone metastasis

From chemical compounds to herbal interventions: a transfer learning-based perturbational transcriptome prediction framework for cancer drug discovery

Exosomal B7H3 drives immunosuppression and serves as a biomarker for PD-1 blockage response in head and neck squamous cell carcinoma

NSAIDs for PI3K-altered head and neck cancer: a biomarker-driven therapeutic opportunity

Erratum to PGK1-coupled HSP90 stabilizes GSK3β expression to regulate the stemness of breast cancer stem cells

Less is more: patients with cervical cancer benefit from de-escalated chemotherapy plus immuno-targeted therapies

Unveiling molecular incomplete response (mIR) via ultra-deep NGS: a novel concept contrasting pathologic complete response (pCR) in occult lymph node micrometastases of non-small cell lung cancer

Ferumoxytol triggers cancer ferroptosis via an NF-κB-driven IRONKILL mechanism

Thermal ablation versus loop electrosurgical excision procedure and cold knife conization for cervical intraepithelial neoplasia: efficacy and HPV clearance in a 5-year cohort of Chinese women

Efficacy and safety of first-line osimertinib in Chinese patients with EGFR-mutated advanced non-small cell lung cancer: a prospective, multicenter, non-interventional study (FLOURISH)

VAMP2/SNAP25 promotes the aggressive progression of head and neck cancer by regulating the fate of multivesicular bodies

Lenvatinib triggers an EGR1-ZNF768-SLC7A11 adaptive response to limit ferroptosis-mediated therapeutic efficacy in hepatocellular carcinoma

Tumor microenvironment-driven natural killer cell diversity: mechanisms and therapeutic opportunities

Evolution in single-cell proteomics drives new frontiers in cancer biology and precision medicine

Machine learning-based clinical decision support tool for advanced ESCC in the immunotherapy era: a multi-center study

Pyroptosis in cancer: a dual regulator of tumor cell fate and immune activation

Circadian-driven transcriptional programs govern metastatic progression

Non-coding RNA delivery via lipid nanoparticles: a novel strategy for cancer immunotherapy

Lactate drives immune resistance via a pharmaceutically reversible H3K18la-KIF20A-c-Myc-PD-L1 axis in hepatocellular carcinoma

Surgery-centered integrated strategies for personalized hepatocellular carcinoma care

Mitochondrial uncoupling inhibits serine catabolism via FTO activation in metastatic breast cancer

Exosomal EPHA2 transfers metastatic potential by stabilizing TGF-βRI and activating the TGF-β/SMAD3 signaling pathway in breast cancer

Single-cell and spatial transcriptome analyses reveal tumor immunometabolism in lymph node metastasis of lung cancer

Blood-based prediction and early detection of pancreatic cancer recurrence after tumor resection

SPRED2 suppresses the stemness of hepatocellular carcinoma through the p53/miR-506-3p/KLF4 pathway

Global disparities in childhood neuroblastoma: trends, burden, and inequities from 1990 to 2021

Comprehensive strategies for management of postoperative hyper-progression recurrence (HPR) of hepatocellular carcinoma: a 12-year large sample multi-center study